Scarica l'app Stockscreener
441.66
1.79%
8.2091
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$433.45
Aprire:
$433.45
Volume 24 ore:
223.29K
Relative Volume:
0.59
Capitalizzazione di mercato:
$9.83B
Reddito:
-
Utile/perdita netta:
$-518.67M
Rapporto P/E:
-17.58
EPS:
-25.12
Flusso di cassa netto:
$-438.32M
1 W Prestazione:
+3.02%
1M Prestazione:
+3.32%
6M Prestazione:
+43.35%
1 anno Prestazione:
+104.65%
Intervallo 1D:
$433.45
$449.02
Intervallo di 1 settimana:
$416.29
$451.41
Portata 52W:
$200.63
$463.62
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Nome
Madrigal Pharmaceuticals Inc
Settore
Industria
Telefono
404-380-9263
Indirizzo
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Confronta MDGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDGL
Madrigal Pharmaceuticals Inc
|
442.72 | 9.74B | 0 | -518.67M | -438.32M | -25.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.57 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.18 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.77 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.46 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.31 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-28 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2025-02-27 | Reiterato | H.C. Wainwright | Buy |
| 2024-06-28 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2024-04-22 | Iniziato | BofA Securities | Underperform |
| 2024-03-15 | Aggiornamento | B. Riley Securities | Sell → Neutral |
| 2024-03-06 | Iniziato | Citigroup | Buy |
| 2024-02-26 | Downgrade | B. Riley Securities | Neutral → Sell |
| 2022-12-20 | Reiterato | Oppenheimer | Outperform |
| 2022-12-19 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-19 | Reiterato | Piper Sandler | Overweight |
| 2022-12-19 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2022-07-08 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-08-06 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-20 | Ripresa | Goldman | Buy |
| 2020-11-24 | Ripresa | Evercore ISI | Outperform |
| 2020-11-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-06-05 | Iniziato | BMO Capital Markets | Market Perform |
| 2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
| 2020-01-30 | Iniziato | Canaccord Genuity | Buy |
| 2020-01-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-07 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-25 | Iniziato | Stifel | Hold |
| 2019-06-10 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2019-02-28 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Outperform |
| 2019-01-23 | Iniziato | UBS | Neutral |
| 2018-12-14 | Iniziato | Wolfe Research | Outperform |
| 2018-12-12 | Iniziato | B. Riley FBR | Neutral |
| 2018-11-19 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2018-11-16 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-09-04 | Iniziato | Citigroup | Buy |
| 2018-08-06 | Downgrade | Goldman | Buy → Neutral |
| 2018-06-28 | Iniziato | Raymond James | Mkt Perform |
Mostra tutto
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
How to use a screener to detect Madrigal Pharmaceuticals Inc. breakoutsPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Applying big data sentiment scoring on Madrigal Pharmaceuticals Inc.Weekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com
Madrigal Pharmaceuticals Inc. recovery potential after sell offPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Detecting support and resistance levels for Madrigal Pharmaceuticals Inc.Inflation Watch & Fast Entry Momentum Alerts - newser.com
Madrigal Pharmaceuticals (MDGL): Piper Sandler Raises Price Targ - GuruFocus
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan - MSN
Truist Securities Initiates Coverage on Madrigal Pharmaceuticals (MDGL) with "Buy" Rating | MDGL Stock News - GuruFocus
Truist Securities initiates coverage on Madrigal Pharmaceuticals stock with Buy rating - Investing.com Canada
Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Potential Upside in the High-Stakes Biotech Arena - DirectorsTalk Interviews
Madrigal Pharmaceuticals Awards Equity Grants to New Employees Under 2023 Inducement Plan - MSN
Sivik Global Healthcare LLC Acquires New Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Live market analysis of Madrigal Pharmaceuticals Inc.Portfolio Performance Report & Consistent Return Investment Signals - newser.com
Wealth Enhancement Advisory Services LLC Acquires New Shares in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (MDGL) Sees Target Price Hike by Oppenh - GuruFocus
Madrigal Pharmaceuticals stock price target raised by Oppenheimer to $590 - Investing.com Canada
How to monitor Madrigal Pharmaceuticals Inc. with trend dashboardsGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Is Madrigal Pharmaceuticals Inc. stock bottoming outTrade Analysis Summary & Weekly Stock Breakout Alerts - newser.com
Will earnings trigger a reversal in Madrigal Pharmaceuticals Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Madrigal Pharmaceuticals (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals gains amid takeover speculation - MSN
Madrigal Pharmaceuticals Reports Promising Two-Year Results for MASH Therapy - MSN
What analysts say about Madrigal Pharmaceuticals Inc YDO1 stockSwing Trading Watchlist & Never Miss the Next Wealth Opportunity - earlytimes.in
Madrigal Pharmaceuticals Inc. stock daily chart insightsGold Moves & Accurate Intraday Trade Tips - newser.com
Market reaction to Madrigal Pharmaceuticals Inc.’s recent news2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Knights of Columbus Asset Advisors LLC Increases Stock Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthTrade Analysis Report & Fast Moving Stock Trade Plans - newser.com
Short interest data insights for Madrigal Pharmaceuticals Inc.Quarterly Profit Summary & AI Enhanced Trading Signals - newser.com
Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep high P E multiplesJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse with 10.5% Upside Potential - DirectorsTalk Interviews
Strid Group LLC Buys Shares of 2,500 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Published on: 2025-10-05 03:01:06 - newser.com
J. Safra Sarasin Holding AG Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals Hits New 52-Week High of $463.48 - Markets Mojo
Signal strength of Madrigal Pharmaceuticals Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Q3 Earnings Estimate for MDGL Issued By B. Riley - Defense World
How to use Fibonacci retracement on Madrigal Pharmaceuticals Inc.Earnings Overview Report & Technical Pattern Based Signals - newser.com
What is B. Riley's Forecast for MDGL Q3 Earnings? - MarketBeat
Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Madrigal Pharmaceuticals Inc Azioni (MDGL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Sibold William John | President and CEO |
Sep 09 '25 |
Sale |
445.63 |
7,279 |
3,243,741 |
102,474 |
4.90%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):